Champions Oncology nets $14 mln

Hackensack, New Jersey-based Champions Oncology Inc, a developer of advanced tech solutions to personalize the use of oncology drugs, has closed $14 million in funding. New Enterprise Associates led the round with participation from other investors that included Battery Ventures, Perceptive Advisors and Sabby Capital. MTS Securities, LLC, an affiliate of MTS Health Partners LP, served as the placement agent.

Champions Oncology Raises $9.3 Million in Private Placement

Champions Oncology of Hackensack, N.J., earlier this week announced it had raised $9.3 million at a price of $0.50 per share in a private placement to existing and new investors. That group includes Battery Ventures IX, L.P., PAR Investment Partners, L.P., members of the company’s management team, and early-stage investor Harris & Harris Group, which invested $200,000 in the financing. No commissions were paid in connection with the private placement.

PE HUB Community

Join the 12514 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget